abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Gross Profit Growth
186.84%
Quarterly · Period ending:
HQL Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported186.84%period ending
Latest reported186.84%period ending
HQL Quarterly Gross Profit YoY % (-11.02% → 186.84%)
Year-over-year change
High-resolution chart · PNG
HQL gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 186.8416% | |
| 379.9528% | |
| 658.8326% | |
| -92.9015% | |
| 7.0489% | |
| 41.6109% | |
| -73.4467% | |
| 47.9489% | |
| -72.1211% | |
| -6.555% | |
| 29.737% | |
| 948.5152% | |
| 1,683.1124% | |
| 32.8956% | |
| 12.9886% | |
| 120.5163% | |
| 126,002.3479% | |
| -667,930.9248% | |
| 10.4969% | |
| -13.5548% | |
| 46.6921% | |
| 102.7838% | |
| 4.8771% | |
| 48.2851% | |
| 288.9971% | |
| -99.981% | |
| 100.0067% | |
| 219.0167% | |
| -46.404% | |
| -109.4017% | |
| -109.4017% | |
| 51.046% | |
| 51.046% | |
| -14.3541% | |
| -14.3541% | |
| -182.4324% | |
| -182.4324% | |
| -17.4603% | |
| -17.4603% | |
| 67.1875% | |
| 67.1875% | |
| 21.9512% | |
| 21.9512% | |
| -34.4262% | |
| -34.4262% | |
| 4.6875% | |
| 4.6875% | |
| -28.8591% | |
| -28.8591% | |
| -14.5038% | |
| -14.5038% | |
| -11.0169% | |
| -11.0169% |